Clinical Trials Directory

Trials / Completed

CompletedNCT06417931

Medication Adherence and Use of Inhaler Devices in Patients With Asthma or COPD

A Pharmacist-Led Intervention on Medication Adherence and Inhaler Usage on Clinical Outcomes Among Patients With Asthma and Chronic Obstructive Pulmonary Disease in Ibadan, Nigeria

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
130 (actual)
Sponsor
University of Ibadan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aims to evaluate the impact of a pharmacist-led intervention programme on medication adherence and use of inhaler devices on clinical outcomes of patients with asthma and COPD attending a tertiary health facility in Nigeria.

Detailed description

Medication non-adherence in asthma and COPD patients have been established to be very high, and along-side poor knowledge of proper use of inhaler devices, results in suboptimal disease control among these patients. Studies evaluating the impact of a comprehensive intervention on medication adherence and inhaler usage on disease control are scare in developing countries. This study was a prospective single-blind quasi-randomized-controlled study among asthma and COPD patients attending the chest out-patient clinic of the University College Hospital, Ibadan. The baseline questionnaire was administered to consenting patients to explore demographic and specific clinical characteristics, knowledge of the disease, current medications, medication adherence, knowledge of use of metered dose (MDIs) and diskus inhalers, and asthma/COPD control status using the asthma control test (ACT) and COPD assessment test (CAT) scales. Subsequently, patients were assigned into intervention or control groups using odd or even number assignation. Patients in the intervention group were followed up for two months via face to face interviews, short message services, and phone calls at one-weekly intervals, so as to provide education and counseling to resolve the identified gaps during the baseline interaction. Descriptive statistics were used to summarize the data, while chi-square, t-test, Fishers exact test and Wilcoxon-signed ranked tests were used as appropriate to test for associations at p \< 0.05.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPatient education and counsellingThe pharmacist intervention was aimed at identifying and addressing barriers to treatment adherence through tailored strategies

Timeline

Start date
2023-10-04
Primary completion
2024-02-28
Completion
2024-02-28
First posted
2024-05-16
Last updated
2024-05-16

Locations

1 site across 1 country: Nigeria

Source: ClinicalTrials.gov record NCT06417931. Inclusion in this directory is not an endorsement.